Please select the option that best describes you:

Do you believe the collective data support neoadjuvant chemotherapy or primary debulking surgery for patients with advanced ovarian cancer?  

Given the recent presentation of the TRUST trial results, the benefit of primary debulking surgery seems less clear. What subgroup(s) of patients do you think should undergo primary debulking surgery?



Answer from: at Community Practice
Comments
at Ascension Sacred Heart Cancer Care
I am a huge advocate for up-front debulking, but i...
at Hacettepe University Faculty of Medicine Ankara
I believe primary debulking remains the preferred ...
Sign In or Register to read more